Prefilled Syringes Market Share, Trends, Opportunities & Growth Analysis 2027

Posted by shriya on June 9th, 2021

Global Medical Cannabis Market Research Report: By Product form (Powders, Solids, Ointments and creams, Oil, Others), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Application (Arthritis, Cancer, Alzheimer’s Disease, Others) and By Distribution Channel (Retail pharmacy, Online stores, Others) – Forecast to 2027


The global market for Medical Cannabis has a better scope for attaining a valuation worth USD 52.35 Billion by 2025. The process would witness growth by 15.4% CAGR between 2019 and 2025, which according to the report of Market Research Future (MRFR) can be considered a forecast period. The global market for medical cannabis has a better chance of growth with the rising instance of chronic diseases and several other medical conditions. These are expected to make significant contributions to manage the growth of the medical cannabis market.

The global market for medical cannabis has substantial growth potential as the market is witnessing its permeation in the healthcare sector for the treatment of cancer, arthritis, schizophrenia, Alzheimer’s disease, and others. Among other factors, the legalization of cannabis-based medicines for the treatment of several diseases and for research purposes are expected to make sure that the market for medical cannabis finds easy growth. Various private and government organizations are showing initiations that can provide scope for growth to the medical cannabis market. However, this is also spurring the illegal intake of cannabis, which can restrain the growth to some extent.

Regional Analysis:

The global market for medical cannabis can have a better understanding of various regions that includes the Americas, the Asia Pacific region, and Europe as major contributing ones. The report also discusses Latin America and the Middle East & Africa (MEA) as regions with scope for further growth.

Competitive Landscape:

Players displaying interest in taking the global medical cannabis market ahead are Aurora Cannabis (Canada), Maricann Inc. (Canada), Tilray (Canada), Canopy Growth Corporation (Canada), Aphria, Inc. (Canada), Medical Marijuana, Inc. (US), GW Pharmaceuticals PLC (UK), United Cannabis (US), CanniMed Ltd (Canada), Cannabis Sativa Inc. (US), GBSciences Inc. (US), MediPharm Labs (Canada), and others. MRFR registered these companies to get close to changes that can impact the market outcome.

Browse More Details at:


Akash Anand

Market Research Future

+1 646 845 9312


Like it? Share it!


About the Author

Joined: May 18th, 2021
Articles Posted: 81

More by this author